- First Opinion Dense breast tissue can complicate mammograms. Women need to know if they have it
- Biotech The Nasdaq’s newest ETF invites investors to bet on Chinese biopharma
- First Opinion Medicare should pay doctors more, not less, for treating the sickest patients
- Biotech A landmark drug approval shows RNAi’s promise — even as it hints at its limits
- Health Medical students are skipping class in droves — and making lectures increasingly obsolete
- Politics Tapered to zero: In radical move, Oregon’s Medicaid program weighs cutting off chronic pain patients from opioids
- Health Medical students are skipping class in droves — and making lectures increasingly obsolete
- Health As Alzheimer’s drug developers give up on today’s patients, where is the outrage?
-
- Don't Miss 8 movies that really got science wrong
- Pharmalot CVS sets a cost-effectiveness threshold for health plan coverage of most new drugs
